Eris Lifesciences Ltd. Financials

NSE BSE

15:57 Jul 18

Eris Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1762.80

-13.50 (-0.76%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1762.80

-13.50 (-0.76%)
15:57 Jul 18

Quality

55/100
High Financial Strength

Valuation

32/100
Mid Valuation

Technical

69/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	1211.86	1347.04	1685.15	2009.14	2893.64
Operating Expenses +	781.29	862.09	1148.4	1334.32	1876.44
Raw Material	276.44	259.29	348.53	379.33	749.46
Increase Decrease in Cost	-38.17	-0.78	3.82	0.72	-35.47
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	229.3	252.25	346.16	403.82	505.09
Miscellaneous Expenses	667.74	634.77	862.55	953.49	1603.6
Operating Profit	430.57	484.95	536.75	674.82	1017.2
Other Income	8.71	26.09	11.15	23.82	18.36
Depreciation	42.98	64.7	117.09	182.6	315.46
Interest	1.8	4.15	26.17	84.8	231.29
Profit before tax and exceptio..	394.5	442.2	404.64	431.24	488.81
Exceptional Items	0	0	0	0	0
PBT	394.5	442.2	404.64	431.24	488.81
Provision for Taxation	39.36	36.41	30.48	34.18	114.2
Net Profit	355.14	405.79	374.16	397.05	374.61
NET Profit after MI	355.14	406.11	382.16	391.98	351.84
EPS	26.14	29.89	28.1	28.82	25.81
Operating Profit Margin (%)	35.53	36	31.85	33.59	35.15
Net Profit Margin (%)	29.31	30.15	22.68	19.51	12.16

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	54.80	54.80	54.90	54.90	54.90
FII	8.40	8.40	8.40	8.00	14.60
MF	16.80	16.60	16.50	17.00	14.50
Others	1.40	1.50	1.50	1.60	1.70

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: